From Our 2011 Archives
Health Highlights: Dec. 21, 2011
Latest MedicineNet News
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
HIV Vaccine Receives FDA Approval for Human Safety Tests
Canadian scientists who created an experimental HIV vaccine that triggers a strong immune response in lab animals have received U.S. Food and Drug Administration approval to begin clinical trials to test the safety of the vaccine in humans.
The Phase I trial will begin in January and will include 40 volunteers who already have HIV, the virus that causes AIDS. If the initial trial is successful, it will be followed by further clinical trials to determine whether the SAV001 vaccine is effective against HIV, CTV News reported.
Previous attempts to create HIV vaccines have used certain genes or proteins from the virus. But this new vaccine uses the whole HIV virus, which has been genetically engineered to prevent it from infecting recipients.
The researchers at the University of Western Ontario in London said the vaccine is designed to prime the body's T-cells to destroy any cells that might become infected with HIV, CTV News reported.
French Officials Consider Recommending Breast Implant Removal
Doctors' warnings about possible rupture and cancer risks associated with a certain type of breast implant have pushed health officials in France to consider whether to recommend that an estimated 30,000 women in the country have their implants removed.
Experts from the French Health Ministry were to meet Friday to decide what to recommend for women with the pre-filled silicone gel implants made by French company Poly Implant Prothese, the Associated Press reported.
More than 1,000 of the implants have ruptured and eight women with the implants have developed cancer, according to French officials. Sales of the implants were halted last year after it was learned that the manufacturer misreported what type of silicone was in the implants.
The decision by French officials could have an effect outside of France because tens of thousands of women in Britain and other countries also have the implants, the AP reported.
U.S. Government Asks Scientists to Withhold Data on New 'Bird Flu' Strain
U.S. officials on Tuesday asked scientists behind a new laboratory-grown strain of "bird flu" to not disclose details of its composition, due to security concerns.
According to the Associated Press, the virus seems to spread more easily among mammals, and government officials worry that publication of its makeup might help terrorists create a biological weapon.
However, experts at the U.S. National Institutes of Health, which funded the research, say publication in scientific journals of the virus' blueprint is important because it suggests the H5N1 strain may mutate more easily than was previously believed.
"It's very important research," NIH science policy director Dr. Amy Patterson told the AP. "As this virus evolves in nature, we want to be able to rapidly detect . . . mutations that may indicate that the virus is getting closer to a form that could cross species lines more readily."
Avian flu strains have, in rare cases, been transmitted from birds to humans. The fear is that a strain of H5N1 might mutate to spread easily person-to-person, sparking a worldwide epidemic. The newly engineered strain appears to do so between ferrets, which have immune system responses to flu that are similar to those seen in people, the AP said.
Based on that result, the U.S. National Science Advisory Board for Biosecurity, which advises the U.S. government, looked over the research as it was being submitted to the journals Science and Nature. The board's recommendation prompted the U.S. Department of Health and Human Services to request that the virus' full genetic blueprint not be published, the AP said.
According to Patterson, the government will allow scientists in the field to be given access to unpublished detail on the genetic makeup of the virus.
The editors-in-chief of Science and Nature have each voiced concerns over the move. "It is essential for public health that the full details of any scientific analysis of flu viruses be available to researchers," Nature editor-in-chief Dr. Philip Campbell said in a statement, adding that the journal is mulling how "appropriate access to the scientific methods and data could be enabled."
Ground Beef Linked to Salmonella Outbreak
Ground beef purchased at Hannaford Supermarkets has been linked to a salmonella outbreak that's sickened 16 people in 7 states, the U.S. Centers for Disease Control and Prevention said Tuesday.
The illnesses began on or after Oct. 8 and there were 4 cases each in Maine, New Hampshire and New York, and one each in Vermont, Kentucky, Massachusetts and Hawaii. Information available for 13 of the ill people shows that 7 have been hospitalized. There have been no deaths.
Preliminary tests show that the outbreak strain of Salmonella Typhimurium is resistant to several commonly prescribed antibiotics, which may increase the risk of hospitalization and possible treatment failure in infected patients, the CDC said.
Maine-based Hannaford Supermarkets on Dec. 15 issued a recall of fresh ground beef products with sell-by dates of Dec. 17 or earlier. Consumers should not eat the recalled ground beef products and restaurant and food service operators should not serve it, the CDC said.
For more information, consumers can call Hannaford's at (800) 213-9040.
Copyright © 2011 HealthDay. All rights reserved.
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions